February 28 - March 2, 2025
OMEZA
OCM™ is the first of it’s kind, HCP administered, drug-device combination product delivering comprehensive therapy to address all phases of wound healing: reduce biofilm impact, decrease inflammation, increase proliferation, and support remodelling. Rich in cold water fish peptides and other pharmaceutical grade components that are natural antimicrobials and non-cytotoxic, this novel treatment provides safe and effective wound management with the ability to use day 1.